TrialCalcified tissue international2022

Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study.

Maria Luisa Brandi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.